• Immunic granted inducement stock options covering 12,900 common shares to three new employees on Oct. 1, 2026.
• Awarded under the 2026 Inducement Equity Compensation Plan.
• Time-vesting terms: 25% on the first anniversary of each hire date.
• Remaining 75% vests monthly in 36 equal installments, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610130630PR_NEWS_USPR_____NY70033) on October 13, 2026, and is solely responsible for the information contained therein.